{
  "resourceType": "Bundle",
  "id": "List-Of-Questions-Response",
  "type": "transaction",
  "entry": [
    {
      "fullUrl": "urn:uuid:task-003",
      "resource": {
        "resourceType": "Task",
        "id": "task-003",
        "status": "completed",
        "intent": "order",
        "code": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/task-code",
              "code": "submit-response",
              "display": "Submit Response to List of Questions"
            }
          ]
        },
        "description": "Submission of responses to the List of Questions for Type II variation (shelf life extension)",
        "for": {
          "reference": "MedicinalProductDefinition/mpd-001"
        },
        "authoredOn": "2025-06-29T18:15:00-04:00",
        "requester": {
          "reference": "Organization/pharma-inc"
        },
        "owner": {
          "reference": "Organization/ema"
        }
      },
      "request": {
        "method": "POST",
        "url": "Task"
      }
    },
    {
      "fullUrl": "urn:uuid:response-bundle-001",
      "resource": {
        "resourceType": "Bundle",
        "id": "response-bundle-001",
        "type": "collection",
        "entry": [
          {
            "fullUrl": "urn:uuid:questionnaire-response-001",
            "resource": {
              "resourceType": "QuestionnaireResponse",
              "id": "questionnaire-response-001",
              "questionnaire": "Questionnaire/questionnaire-001",
              "status": "completed",
              "authored": "2025-06-29T18:15:00-04:00",
              "item": [
                {
                  "linkId": "admin-1",
                  "text": "Is the fee for the Type II variation fully paid and documented?",
                  "answer": [
                    {
                      "valueString": "Yes, the fee was paid on June 25, 2025, with documentation included in the application form."
                    }
                  ]
                },
                {
                  "linkId": "admin-2",
                  "text": "Are all required metadata fields in the application form complete?",
                  "answer": [
                    {
                      "valueString": "All metadata fields are complete, as verified against EMA guidelines."
                    }
                  ]
                },
                {
                  "linkId": "labeling-1",
                  "text": "Do the updated storage conditions (2-8°C for 36 months) require additional patient guidance?",
                  "answer": [
                    {
                      "valueString": "No additional guidance is needed; the ePI clearly states storage at 2-8°C for 36 months."
                    }
                  ]
                },
                {
                  "linkId": "labeling-2",
                  "text": "Is the patient leaflet revised to clarify the extended shelf life?",
                  "answer": [
                    {
                      "valueString": "Yes, the patient leaflet has been updated to reflect the 36-month shelf life."
                    }
                  ]
                },
                {
                  "linkId": "labeling-3",
                  "text": "Is the updated ePI text sufficiently clear for all EU languages?",
                  "answer": [
                    {
                      "valueString": "The ePI text has been translated and reviewed for clarity in all EU languages."
                    }
                  ]
                },
                {
                  "linkId": "cmc-1",
                  "text": "Do stability studies cover all required environmental conditions for 36 months?",
                  "answer": [
                    {
                      "valueString": "Yes, stability studies include temperature, humidity, and light conditions for 36 months, per ICH guidelines."
                    }
                  ]
                },
                {
                  "linkId": "cmc-2",
                  "text": "Are analytical methods validated for detecting degradation over 36 months?",
                  "answer": [
                    {
                      "valueString": "Analytical methods are fully validated, with results included in the PQI submission."
                    }
                  ]
                },
                {
                  "linkId": "cmc-3",
                  "text": "Are new impurities identified in extended stability studies?",
                  "answer": [
                    {
                      "valueString": "No new impurities were identified; all impurities are within acceptable limits."
                    }
                  ]
                },
                {
                  "linkId": "cmc-4",
                  "text": "Is the container closure system validated for 36 months?",
                  "answer": [
                    {
                      "valueString": "The container closure system is validated for 36 months, with supporting data in the PQI Bundle."
                    },
                    {
                      "valueAttachment": {
                        "contentType": "image/svg+xml",
                        "data": "PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHdpZHRoPSIxMDAiIGhlaWdodD0iMTAwIj48cmVjdCB3aWR0aD0iMTAwIiBoZWlnaHQ9IjEwMCIgZmlsbD0iI2ZmZiIvPjx0ZXh0IHg9IjUwIiB5PSI1MCIgZm9udC1zaXplPSIxNSIgZmlsbD0iIzAwMCIgdGV4dC1hbmNob3I9Im1pZGRsZSI+U1ZHIFBsYWNlaG9sZGVyPC90ZXh0Pjwvc3ZnPg==",
                        "title": "Container Closure System Diagram"
                      }
                    }
                  ]
                },
                {
                  "linkId": "cmc-5",
                  "text": "Are degradation products fully characterized for 36 months?",
                  "answer": [
                    {
                      "valueString": "Degradation products are fully characterized. No significant changes were observed in the 36-month stability studies.\nAll identified degradation products remain within acceptable limits, as detailed in the PQI submission."
                    }
                  ]
                }
              ]
            }
          }
        ]
      },
      "request": {
        "method": "POST",
        "url": "Bundle"
      }
    },
    {
      "fullUrl": "urn:uuid:provenance-003",
      "resource": {
        "resourceType": "Provenance",
        "id": "provenance-003",
        "target": [
          {
            "reference": "Bundle/response-bundle-001"
          }
        ],
        "recorded": "2025-06-29T18:15:00-04:00",
        "agent": [
          {
            "type": {
              "coding": [
                {
                  "system": "http://hl7.org/fhir/provenance-participant-type",
                  "code": "author"
                }
              ]
            },
            "who": {
              "reference": "Organization/pharma-inc"
            }
          }
        ],
        "signature": [
          {
            "type": [
              {
                "system": "urn:iso-astm:E1762-95:2013",
                "code": "1.2.840.10065.1.12.1.1"
              }
            ],
            "when": "2025-06-29T18:15:00-04:00",
            "who": {
              "reference": "Organization/pharma-inc"
            }
          }
        ]
      },
      "request": {
        "method": "POST",
        "url": "Provenance"
      }
    }
  ]
}